Generally speaking to see if the treatment work and improves patients quality of life.

A primary endpoint in cancer clinical trials is usually survival: a direct, measurable outcome based on the drug’s expected effects. A secondary endpoint, such as quality of life, may be chosen to explore additional benefit the patient may gain including functional and emotional status.